2012
DOI: 10.1016/j.cca.2012.09.012
|View full text |Cite
|
Sign up to set email alerts
|

High-resolution melting: Applications in genetic disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
46
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 75 publications
(48 citation statements)
references
References 50 publications
0
46
0
1
Order By: Relevance
“…Heterozygotes are easily identified from their melting curves but homozygotes are more difficult to detect. 19) We have identified 2 mutations (p.T309I in KCNQ1 and p.R744fs in KCNH2) and 11 polymorphisms in 5 Taiwanese LQTS patients and the family members of 3 LQTS patients referred for three-gene screening. These mutations and polymorphisms have previously been described.…”
Section: Discussionmentioning
confidence: 99%
“…Heterozygotes are easily identified from their melting curves but homozygotes are more difficult to detect. 19) We have identified 2 mutations (p.T309I in KCNQ1 and p.R744fs in KCNH2) and 11 polymorphisms in 5 Taiwanese LQTS patients and the family members of 3 LQTS patients referred for three-gene screening. These mutations and polymorphisms have previously been described.…”
Section: Discussionmentioning
confidence: 99%
“…The HRM PCR is a closed-tube and post-PCR method that enables rapid analysis of genetic sequences (Wittwer, 2009;Vossen et al, 2009;Er and Chang, 2012;Wojdacz, 2012). However, few genotypes and markers have been tested and it is unclear whether HRM can be used as an alternative to electrophoresis-based methods for microsatellite detection.…”
Section: Introductionmentioning
confidence: 99%
“…High-resolution melting of PCR products is a simple and popular method for detecting and genotyping sequence variants (1)(2)(3). Scanning for genetic variants by high-resolution melting typically reduces sequencing needs by about 90% (4 ).…”
mentioning
confidence: 99%
“…Even when scanning conditions are carefully designed to optimize analytical specificity, polymorphisms that are not of clinical interest are found in about 5% of CFTR [cystic fibrosis transmembrane conductance regulator (ATPbinding cassette sub-family C, member 7)] amplicons (7,8 ) and in 7% of BRCA1 and BRCA2 (breast cancer 2, early onset) amplicons (4,9 ). Although scanning is an inexpensive, simple approach with an analytical sensitivity approaching 100% (1)(2)(3), its advantage over comprehensive sequencing depends strongly on minimizing subsequent analyses.…”
mentioning
confidence: 99%